At week 24 , treatment with etanercept resulted in response rates of 93 % , 93 % , 80 % , 56 % , and 54 % based on the ACR Pedi 30 , Pedi 50 , Pedi 70 , Pedi 90 , and Pedi 100 criteria , respectively .